by MiNDSET | Apr 21, 2026 | Studies & News |
What New Lancet Research Means for Depression Treatment Major depressive disorder (MDD) remains one of the most challenging mental health conditions to treat—particularly when patients experience suicidal thoughts. One of the greatest limitations in traditional care...
by MiNDSET | Nov 14, 2025 | Studies & News |
As a physician who has spent more than three decades treating patients with complex mental health and pain conditions, I know how urgently we need better solutions—especially for veterans living with PTSD, treatment-resistant depression, and anxiety disorders. That’s...
by Dr. David Caldwell | Nov 14, 2025 | A Word from the Doctors |
At MiNDSET, we’ve always grounded our care in clinical evidence and medical oversight—not in trends. The recent Neuropharmacology study by Prochazkova and colleagues (2025) underscores why that distinction matters. The Science Speaks: No Real Benefits from Microdosing...
by MiNDSET | Oct 28, 2025 | Studies & News |
A major shift is underway. Health Canada has officially recognized ketamine as a National Priority Drug, marking a turning point in how this powerful therapy is understood and supported across the country. At MiNDSET Integrative Ketamine Care, we see this as more than...
by MiNDSET | Oct 22, 2025 | Studies & News |
What a New JAMA Study Reveals — and Why Integration Still Matters** In recent months, conversation around psychedelic medicine has shifted from curiosity to clinical seriousness. The latest editorial in JAMA — “Are Psychedelic Agents Ready for Prime Time as...
by Dr. David Caldwell | Sep 26, 2025 | A Word from the Doctors |
By Dr. David Caldwell, Founder of MiNDSET Integrative Ketamine Care Mental health disorders such as depression and anxiety continue to rise across the United States, yet the number of psychiatrists available to provide specialized care has not kept pace. Today, more...
by Dr. David Caldwell | Sep 24, 2025 | A Word from the Doctors |
By Dr. David Caldwell, Founder of MiNDSET Integrative Ketamine Care For decades, patients suffering from treatment-resistant depression (TRD), PTSD, anxiety, and chronic pain have faced a frustrating reality: traditional treatment options often fail to provide relief,...
by Dr M | Aug 14, 2025 | A Word from the Doctors |
Ketamine Infusion Therapy Collaborative Community Conversation: Our Mission at MiNDSET At MiNDSET, we are committed to advancing the field of interventional psychiatry through evidence-based practice, professional collaboration, and ethical innovation. Our mission...
by MiNDSET | Aug 5, 2025 | Studies & News |
What Is Neuroplasticity? Neuroplasticity is the brain’s ability to reorganize itself by forming new neural connections throughout life. It’s how we learn new skills, form memories, and recover from trauma. In conditions like depression, anxiety, and PTSD,...
by MiNDSET | Jul 25, 2025 | A Word from the Doctors |
“What if the path to healing didn’t require you to talk it all out first—but to feel it, safely, in silence?” That’s the kind of radical, yet deeply human, idea at the heart of MiNDSET Integrative Ketamine Care, featured on this week’s episode of The Keri...
